Skip to Main Content

Author Details

Claude Preudhomme
Lille University Hospital, INSERM UMR-S7, CNRS UMR9020, Lille University.
1989
384
77
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37698981Three UBA1 clones for a unique VEXAS syndrome.Rheumatology (Oxford)2024
37855058Small myeloid subclones are present at diagnosis of multiple myeloma in patients who develop secondary myelodysplastic syndromes.Haematologica2024
36394159Real-life challenges using personalized prognostic scoring systems in acute myeloid leukemia.Cancer Med2023
38093739Negative Impact of <i>TET2</i> Mutations on Long-Term Survival After Transcatheter Aortic Valve Replacement.JACC Basic Transl Sci2023
37637995Targeted High-throughput Sequencing for Hematological Malignancies: A GBMHM Survey of Practice and Cost Evaluation in France.Hemasphere2023
37085611UBTF tandem duplications define a distinct subtype of adult de novo acute myeloid leukemia.Leukemia2023
37205853LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study.Blood Adv2023
37406166Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41.Blood Adv2023
37328541Prognostic impact of RUNX1 mutations and deletions in pediatric acute myeloid leukemia: results from the French ELAM02 study group.Leukemia2023
34714914Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience.Blood Adv2022
35443031Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study.Blood2022
35438802A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher-Risk MDS or low blast AML: GFM's "pick a winner" trial, with the impact of somatic mutations.Br J Haematol2022
35750691A multiparametric niche-like drug screening platform in acute myeloid leukemia.Blood Cancer J2022
35618837A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia.Nat Med2022
36570694Relative Mitochondrial Priming Predicts Survival in Older AML Patients Treated Intensively.Hemasphere2022
36494771Publisher Correction: Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r.BMC Bioinformatics2022
36041908[GATA2 gene mutations: 3 cases].Rev Med Interne2022
36307762Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r.BMC Bioinformatics2022
36151081Hematopoietic differentiation at single-cell resolution in NPM1-mutated AML.Blood Cancer J2022
35256762Molecular heterogeneity and measurable residual disease of rare NPM1 mutations in acute myeloid leukemia: a nationwide experience from the GBMHM study group.Leukemia2022
34983928Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia.Nat Commun2022
35008099Prognostic impact of ABCA3 expression in adult and pediatric acute myeloid leukemia: an ALFA-ELAM02 joint study.Blood Adv2022
35176141Clonal haematopoiesis of indeterminate potential and cardiovascular events in systemic lupus erythematosus (HEMATOPLUS study).Rheumatology (Oxford)2022
34615986Machine learning identifies the independent role of dysplasia in the prediction of response to chemotherapy in AML.Leukemia2022
32554555Germline pathogenic variants in transcription factors predisposing to pediatric acute myeloid leukemia: results from the French ELAM02 trial.Haematologica2021
33687433Transcriptomic and genomic heterogeneity in blastic plasmacytoid dendritic cell neoplasms: from ontogeny to oncogenesis.Blood Adv2021
33881523Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML: an ALFA study.Blood2021
33906574Targeting RUNX1 in acute myeloid leukemia: preclinical innovations and therapeutic implications.Expert Opin Ther Targets2021
33623140Genomic landscape of MDS/CMML associated with systemic inflammatory and autoimmune disease.Leukemia2021
33778416Hereditary Predisposition to Acute Myeloid Leukemia in Older Adults.Hemasphere2021
34410352Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy.Blood2021
34700215Standardisation of pathogenicity classification for somatic alterations in solid tumours and haematologic malignancies.Eur J Cancer2021
347245632021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party.Blood2021
34805765Improvement of Standardization of Molecular Analyses in Hematology: The 10-year GBMHM French Experience.Hemasphere2021
34625784Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML.Blood Adv2021
34344988Prevalence of UBA1 mutations in MDS/CMML patients with systemic inflammatory and auto-immune disease.Leukemia2021
33982372Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias.Genes Chromosomes Cancer2021
34233450The RUNX1 database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy.Haematologica2021
33973227Characterisation of Asp669Tyr Piezo1 cation channel activity in red blood cells: an unexpected phenotype.Br J Haematol2021
33054115Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscapeHaematologica2021
33299234Minimal residual disease monitoring in acute myeloid leukemia with non-A/B/D-NPM1 mutations by digital polymerase chain reaction: feasibility and clinical use.Haematologica2021
33043739Effects of azacitidine in 93 patients with <i>IDH1/2</i> mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter study.Leuk Lymphoma2021
33036026Germline PAX5 mutation predisposes to familial B-cell precursor acute lymphoblastic leukemia.Blood2021
32655144A transcriptomic continuum of differentiation arrest identifies myeloid interface acute leukemias with poor prognosis.Leukemia2021
32871585A personalized approach to guide allogeneic stem cell transplantation in younger adults with acute myeloid leukemia.Blood2021
30987895Immature platelet fraction (IPF): A reliable tool to predict peripheral thrombocytopenia.Curr Res Transl Med2020
31968250Vitamin D Receptor Controls Cell Stemness in Acute Myeloid Leukemia and in Normal Bone Marrow.Cell Rep2020
31988437Disease escape with the selective loss of the Philadelphia chromosome after tyrosine kinase inhibitor exposure in Ph-positive acute lymphoblastic leukemia.Leukemia2020
32098966The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants.Nat Commun2020
31827242Familial myeloid malignancies with germline TET2 mutation.Leukemia2020
  • 1 - 50 of 384

Recommended Authors

Ann-Kathrin Eisfeld
The Ohio State University Comprehensive Cancer Center
Career Start Year 2011
Number of shared co-authors 2
Bartlomiej Przychodzen
Vanda Pharmaceuticals Inc.
Career Start Year 2010
Number of shared co-authors 7
Jennifer Dunlap
Oregon Health & Science University
Career Start Year 2008
Number of shared co-authors 1
Paulo Vidal Campregher
Hospital Israelita Albert Einstein
Career Start Year 2007
Number of shared co-authors 1
Rashmi Kanagal-Shamanna
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 8
Jamshid S Khorashad
Institute of Cancer Research
Career Start Year 2006
Number of shared co-authors 3
Michelle O'Laughlin
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 2003
Number of shared co-authors 2
Gudrun G??hring
Hannover Medical School
Career Start Year 2002
Number of shared co-authors 14
Thomas Ernst
Universitatsklinikum Jena
Career Start Year 2002
Number of shared co-authors 7
Alexander Kohlmann
Oncology R&D
Career Start Year 2002
Number of shared co-authors 6
Guang Fan
Oregon Health and Science University
Career Start Year 2000
Number of shared co-authors 0
Lukas D Wartman
Washington University School of Medicine in St. Louis
Career Start Year 1998
Number of shared co-authors 3
Markus Metzler
University Hospital Erlangen
Career Start Year 1998
Number of shared co-authors 4
Michael W Deininger
University of Utah Huntsman Cancer Institute
Career Start Year 1997
Number of shared co-authors 10
Guillermo Garcia-Manero
MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 19
Brian J P Huntly
University of Cambridge
Career Start Year 1996
Number of shared co-authors 28
Bruno C Medeiros
AbbVie Inc.
Career Start Year 1996
Number of shared co-authors 12
Matthew J Walter
Washington University School of Medicine in St. Louis
Career Start Year 1994
Number of shared co-authors 10
Mar??a D Odero
University of Navarra
Career Start Year 1994
Number of shared co-authors 0
Timothy A Graubert
Massachusetts General Hospital
Career Start Year 1993
Number of shared co-authors 9
Arndt Borkhardt
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Career Start Year 1992
Number of shared co-authors 8
Derek L Stirewalt
Fred Hutchinson Cancer Center
Career Start Year 1992
Number of shared co-authors 4
Gautam Borthakur
MD Anderson Cancer Center
Career Start Year 1992
Number of shared co-authors 11
Christopher D Gocke
Johns Hopkins University School of Medicine
Career Start Year 1992
Number of shared co-authors 1
Jerald P Radich
Fred Hutchinson Cancer Center
Career Start Year 1989
Number of shared co-authors 15
Suzanne Kamel-Reid
Toronto General Hospital, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 6
Krzysztof Mr??zek
The Ohio State Comprehensive Cancer Center
Career Start Year 1988
Number of shared co-authors 4
Richard M Stone
Dana Farber Cancer Institute
Career Start Year 1986
Number of shared co-authors 34
Steven M Kornblau
The University of Texas MD Anderson Cancer Center
Career Start Year 1980
Number of shared co-authors 18
Robin Fo??
Sapienza University.
Career Start Year 1968
Number of shared co-authors 7

Collaborators

Herv?? Dombret
Institut de Recherche Saint-Louis, Universite de Paris
Co-authored papers 90
Emmanuel Raffoux
Universite Paris Diderot
Co-authored papers 38
Claude Gardin
Avicenne Hospital
Co-authored papers 35
Raphael Itzykson
Universite Paris Cite, INSERM, CNRS
Co-authored papers 29
Lionel Ad??s
Assistance Publique des Hopitaux de Paris (AP-HP)
Co-authored papers 26
Jean-Baptiste Micol
INSERM U7, Universite Paris-Saclay
Co-authored papers 21
Thorsten Braun
Centre Hospitalier Universitaire Hopital Avicenne
Co-authored papers 14
Emmanuelle Clappier
Saint-Louis Hospital
Co-authored papers 13
Thomas Cluzeau
Universite Nice Cote d'azur, CHU de Nice
Co-authored papers 12
Matthieu Duchmann
Assistance Publique-Hopitaux de Paris, Universite de Paris
Co-authored papers 9
Jean Soulier
University of Paris
Co-authored papers 9
Daniel Birnbaum
Co-authored papers 6
Alexandre Puissant
Universite de Paris, INSERM, CNRS
Co-authored papers 6
Rémi Favier
Co-authored papers 5
Torsten Haferlach
Taussig Cancer Institute, Cleveland Clinic
Co-authored papers 5
Cl??mentine Chauvel
Universite Paris Cite, INSERM, CNRS
Co-authored papers 4
Reinaldo Dal Bello
Universite Paris Cite, INSERM, CNRS
Co-authored papers 4
Christoph R??llig
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 3
Hugues de Th??
Universite Paris Cite, Inserm, CNRS, Institut de Recherche Saint-Louis
Co-authored papers 3
Patrick Auberger
Universite Cote d'Azur, INSERM U5
Co-authored papers 3
Bert A van der Reijden
Co-authored papers 3
John E Dick
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
Il??ana Antony-Debr??
INSERM, France Villejuif Universite Paris-Saclay
Co-authored papers 3
Lucy A Godley
The University of Chicago
Co-authored papers 2
Friedrich St??lzel
University Hospital TU Dresden
Co-authored papers 2
Philippe Amouyel
Co-authored papers 2
Nina Fenouille
Universite Paris Cite, INSERM, CNRS
Co-authored papers 2
Lina Benajiba
Universite de Paris, Inserm CIC 1427
Co-authored papers 2
Arnaud Jacquel
Universite Cote d'Azur, INSERM U5
Co-authored papers 2
Gaetano Sodaro
Universite Paris Cite, INSERM, CNRS
Co-authored papers 2
Release 1.2